Skip to content

Testing a New Device to Check Blood Pressure in Pregnant Women

A prospective validation study on the accuracy of a novel device for measuring blood pressure in pregnant women - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107701
Enrollment
255
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Intervention1: Nil: Nil

Sponsors

Concept Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women in second and third trimester with a viable pregnancy 2. Willing and able to consent to participate 3. Singleton or multiple pregnancy

Exclusion criteria

Exclusion criteria: 1. Pregnant woman is clinically unstable (such as eclampsia, imminent delivery, severe haemorrhage) or delivery is imminent (active labour) 2. Woman receiving intravenous vasoactive medication (such as vasopressor or inotrope therapy) 3. Known cardiac arrhythmia 4. Women in whom a paediatric-sized cuff is required for blood pressure measurement 5. women less than, 18 years of age.

Design outcomes

Primary

MeasureTime frame
Accuracy of a novel blood pressure measurement device in pregnant womenTimepoint: Between 14-40 weeks Gestational age (Second and Third Trimester)

Secondary

MeasureTime frame
Usability, feasibility & acceptability of the novel device in these care settings,Timepoint: Between 14-40 weeks Gestational age (Second & Third Trimester)

Countries

Ghana, India, Kenya

Contacts

Public ContactDr Shivaprasad S Goudar

KLE Academy of Higher Education and Researchs J N Medical College

sgoudar@jnmc.edu09448126371

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026